-
Something wrong with this record ?
Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition
Z. Parackova, P. Vrabcova, I. Zentsova, A. Sediva, M. Bloomfield
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Medline Complete (EBSCOhost)
from 2010-01-01
Public Health Database (ProQuest)
from 2023-01-01 to 2023-12-31
Springer Nature OA/Free Journals
from 1981-01-01
- MeSH
- Gain of Function Mutation * MeSH
- Autoimmunity MeSH
- Phenotype MeSH
- Phosphorylation MeSH
- Candidiasis, Chronic Mucocutaneous * drug therapy genetics MeSH
- Humans MeSH
- Neutrophils metabolism MeSH
- STAT1 Transcription Factor * metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
STAT1 gain-of-function (GOF) mutations cause an inborn error of immunity with diverse phenotype ranging from chronic mucocutaneous candidiasis (CMC) to various non-infectious manifestations, the most precarious of which are autoimmunity and vascular complications. The pathogenesis centers around Th17 failure but is far from being understood. We hypothesized that neutrophils, whose functions have not been explored in the context of STAT1 GOF CMC yet, might be involved in the associated immunodysregulatory and vascular pathology. In a cohort of ten patients, we demonstrate that STAT1 GOF human ex-vivo peripheral blood neutrophils are immature and highly activated; have strong propensity for degranulation, NETosis, and platelet-neutrophil aggregation; and display marked inflammatory bias. STAT1 GOF neutrophils exhibit increased basal STAT1 phosphorylation and expression of IFN stimulated genes, but contrary to other immune cells, STAT1 GOF neutrophils do not display hyperphosphorylation of STAT1 molecule upon stimulation with IFNs. The patient treatment with JAKinib ruxolitinib does not ameliorate the observed neutrophil aberrations. To our knowledge, this is the first work describing features of peripheral neutrophils in STAT1 GOF CMC. The presented data suggest that neutrophils may contribute to the immune pathophysiology of the STAT1 GOF CMC.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016142
- 003
- CZ-PrNML
- 005
- 20231026110321.0
- 007
- ta
- 008
- 231013s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10875-023-01528-1 $2 doi
- 035 __
- $a (PubMed)37358695
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Parackova, Zuzana $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic. zuzana.parackova@lfmotol.cuni.cz $1 https://orcid.org/000000022398532X $7 xx0231004
- 245 10
- $a Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition / $c Z. Parackova, P. Vrabcova, I. Zentsova, A. Sediva, M. Bloomfield
- 520 9_
- $a STAT1 gain-of-function (GOF) mutations cause an inborn error of immunity with diverse phenotype ranging from chronic mucocutaneous candidiasis (CMC) to various non-infectious manifestations, the most precarious of which are autoimmunity and vascular complications. The pathogenesis centers around Th17 failure but is far from being understood. We hypothesized that neutrophils, whose functions have not been explored in the context of STAT1 GOF CMC yet, might be involved in the associated immunodysregulatory and vascular pathology. In a cohort of ten patients, we demonstrate that STAT1 GOF human ex-vivo peripheral blood neutrophils are immature and highly activated; have strong propensity for degranulation, NETosis, and platelet-neutrophil aggregation; and display marked inflammatory bias. STAT1 GOF neutrophils exhibit increased basal STAT1 phosphorylation and expression of IFN stimulated genes, but contrary to other immune cells, STAT1 GOF neutrophils do not display hyperphosphorylation of STAT1 molecule upon stimulation with IFNs. The patient treatment with JAKinib ruxolitinib does not ameliorate the observed neutrophil aberrations. To our knowledge, this is the first work describing features of peripheral neutrophils in STAT1 GOF CMC. The presented data suggest that neutrophils may contribute to the immune pathophysiology of the STAT1 GOF CMC.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a autoimunita $7 D015551
- 650 12
- $a kandidóza chronická mukokutánní $x farmakoterapie $x genetika $7 D002178
- 650 12
- $a aktivační mutace $7 D000073659
- 650 _2
- $a neutrofily $x metabolismus $7 D009504
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a fosforylace $7 D010766
- 650 12
- $a transkripční faktor STAT1 $x metabolismus $7 D050794
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vrabcova, Petra $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
- 700 1_
- $a Zentsova, Irena $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
- 700 1_
- $a Sediva, Anna $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
- 700 1_
- $a Bloomfield, Marketa $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
- 773 0_
- $w MED00002589 $t Journal of clinical immunology $x 1573-2592 $g Roč. 43, č. 7 (2023), s. 1640-1659
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37358695 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110315 $b ABA008
- 999 __
- $a ok $b bmc $g 1999956 $s 1202504
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 43 $c 7 $d 1640-1659 $e 20230626 $i 1573-2592 $m Journal of clinical immunology $n J Clin Immunol $x MED00002589
- LZP __
- $a Pubmed-20231013